Operating Cash Flow (Statement)

$359.87M

TTM · Period ending: Jun 30, 2026 · USD

Latest reported$359.87Mperiod endingJun 30, 2026

BCRX TTM Cash from Operations (-$6.50M → $359.87M)

TTM operating cash flow (statement)

High-resolution chart · PNG

BCRX operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Biocryst Pharmaceuticals Inc Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period ending	Operating Cash Flow (Statement) (USD)
Jun 30, 2001	-8,614,640
Mar 31, 2001	-7,735,463
Dec 31, 2000	-3,177,640
Sep 30, 2000	-1,698,000
Jun 30, 2000	-1,658,000
Mar 31, 2000	26,823
Dec 31, 1999	-4,900,000
Sep 30, 1999	-500,000
Jun 30, 1999	-1,200,000
Mar 31, 1999	-4,200,000
Dec 31, 1998	-4,200,000
Sep 30, 1998	-11,300,000
Jun 30, 1998	-11,000,000
Mar 31, 1998	-9,700,000
Dec 31, 1997	-10,300,000
Sep 30, 1997	-8,900,000
Jun 30, 1997	-8,700,000
Mar 31, 1997	-8,000,000
Dec 31, 1996	-6,800,000
Sep 30, 1996	-6,800,000
Jun 30, 1996	-6,300,000
Mar 31, 1996	-6,600,000
Dec 31, 1995	-7,700,000
Sep 30, 1995	-7,600,000
Jun 30, 1995	-7,700,000
Mar 31, 1995	-7,900,000
Dec 31, 1994	-6,500,000